Neuropsychiatric Problems Associated With Lupus

Slideshow

A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.

Recent Videos
Martin Tolar, MD, PhD
Patricia K. Coyle, MD
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Martin Tolar, MD, PhD
Related Content
FDA Clears IND for CAR-T Cell Therapy Equecabtagene Autoleucel in Multiple Sclerosis

FDA Clears IND for CAR-T Cell Therapy Equecabtagene Autoleucel in Multiple Sclerosis

Marco Meglio
July 25th 2024
Article
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

Marco Meglio
July 12th 2024
Podcast
Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data

Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data

Marco Meglio
July 24th 2024
Article
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

Marco Meglio
July 9th 2024
Podcast
Peter Kang, MD, FAAN, FAAP (Credit: University of Minnesota)

FDA Clears IND Application for Myogenica’s MyoPAXon in Muscular Dystrophy

Isabella Ciccone, MPH
July 24th 2024
Article
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data

Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data

Marco Meglio
July 24th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.